DE69702209D1 - Stoffe und verfahren in zusammenhang mit der diagnose und therapie der präeclampsie - Google Patents

Stoffe und verfahren in zusammenhang mit der diagnose und therapie der präeclampsie

Info

Publication number
DE69702209D1
DE69702209D1 DE69702209T DE69702209T DE69702209D1 DE 69702209 D1 DE69702209 D1 DE 69702209D1 DE 69702209 T DE69702209 T DE 69702209T DE 69702209 T DE69702209 T DE 69702209T DE 69702209 D1 DE69702209 D1 DE 69702209D1
Authority
DE
Germany
Prior art keywords
diagnosis
eclampsia
preclampsy
therapy
substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69702209T
Other languages
English (en)
Other versions
DE69702209T2 (de
Inventor
William Rademacher
Patricia Mclean
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Silence Therapeutics PLC
Original Assignee
Rademacher Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rademacher Group Ltd filed Critical Rademacher Group Ltd
Publication of DE69702209D1 publication Critical patent/DE69702209D1/de
Application granted granted Critical
Publication of DE69702209T2 publication Critical patent/DE69702209T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Materials For Medical Uses (AREA)
DE69702209T 1996-09-11 1997-09-11 Stoffe und verfahren in zusammenhang mit der diagnose und therapie der präeclampsie Expired - Lifetime DE69702209T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9618931.1A GB9618931D0 (en) 1996-09-11 1996-09-11 Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
PCT/GB1997/002534 WO1998010791A1 (en) 1996-09-11 1997-09-11 Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes

Publications (2)

Publication Number Publication Date
DE69702209D1 true DE69702209D1 (de) 2000-07-06
DE69702209T2 DE69702209T2 (de) 2000-11-09

Family

ID=10799739

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69702209T Expired - Lifetime DE69702209T2 (de) 1996-09-11 1997-09-11 Stoffe und verfahren in zusammenhang mit der diagnose und therapie der präeclampsie

Country Status (14)

Country Link
US (2) US6495330B1 (de)
EP (1) EP0939651B1 (de)
JP (1) JP4457191B2 (de)
CN (1) CN1146445C (de)
AT (1) ATE193452T1 (de)
AU (1) AU715884B2 (de)
BR (1) BR9711752A (de)
CA (1) CA2264939C (de)
DE (1) DE69702209T2 (de)
DK (1) DK0939651T3 (de)
ES (1) ES2148967T3 (de)
GB (1) GB9618931D0 (de)
IL (1) IL128893A0 (de)
WO (1) WO1998010791A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618930D0 (en) * 1996-09-11 1996-10-23 Univ London Metal containing carbohydrates from human tissue which regulate lipogenic activity
GB9618931D0 (en) * 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
GB9801899D0 (en) * 1998-01-29 1998-03-25 Univ London Neurotrophic properties of ipgs analogues
US20040192586A1 (en) * 1998-03-18 2004-09-30 Rodaris Pharmaceuticals Limited Materials and methods relating to anti-inositolphosphoglycan antibodies
WO1999047565A1 (en) * 1998-03-18 1999-09-23 Rademacher Group Limited Anti-inositolphosphoglycan monoclonal antibodies
GB9806645D0 (en) * 1998-03-27 1998-05-27 Univ London Materials and methods relating to the treatment of conditions involving mast cells,basophils and eosinophils
GB9828564D0 (en) * 1998-12-23 1999-02-17 Rademacher Group Limited Materials and methods for the treatment and diagnosis of cancer
GB9914326D0 (en) * 1999-06-18 1999-08-18 Rademacher Group Limited Materials and methods relating to the diagnosis and treatment of pre-eclampsia
GB9927125D0 (en) * 1999-11-16 2000-01-12 Univ Reading The Placental human neurokinin B precursor
US6953781B2 (en) 2000-05-12 2005-10-11 Rodaris Pharmaceuticals Limited Compounds and their uses
US6759390B2 (en) 2000-05-12 2004-07-06 Manuel Martin-Lomas Compounds and their uses
CA2433854A1 (en) * 2000-05-12 2001-11-15 Rodaris Pharmaceuticals Limited Inositol phosphoglycan derivatives and their medical uses
US6939857B2 (en) 2000-05-12 2005-09-06 Rodaris Pharmaceuticals Limited Compounds and their uses
US6716826B2 (en) 2000-05-12 2004-04-06 Rodaris Pharmaceuticals Limited Compounds and their uses
WO2001085745A1 (en) * 2000-05-12 2001-11-15 Rodaris Pharmaceuticals Limited Inositol phosphoglycan derivatives and their medical uses
JP2003532896A (ja) * 2000-05-12 2003-11-05 ロダリス・ファーマシューティカルズ・リミテッド Ｉｐｇアッセイ
GB0015625D0 (en) * 2000-06-26 2000-08-16 Univ London Materials and methods relating for the treatment and diagnosis of pre-eclampsia
WO2004071273A2 (en) * 2003-02-04 2004-08-26 The Administrators Of The Tulane Educational Fund Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
SG155257A1 (en) * 2004-09-24 2009-09-30 Beth Israel Hospital Methods of diagnosing and treating complications of pregnancy
WO2010091253A1 (en) 2009-02-06 2010-08-12 Women & Infants' Hospital Of Rhode Island Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
WO2019166556A1 (en) 2018-02-28 2019-09-06 Pharming Intellectual Property B.V. Treatment and prevention of pre-eclampsia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0412700B1 (de) * 1989-08-03 1998-03-11 The Regents Of The University Of California Verfahren zur Isolierung von fetalen Zytotrophoblastzellen
GB9618931D0 (en) * 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
US20040192586A1 (en) * 1998-03-18 2004-09-30 Rodaris Pharmaceuticals Limited Materials and methods relating to anti-inositolphosphoglycan antibodies

Also Published As

Publication number Publication date
WO1998010791A1 (en) 1998-03-19
JP2001501598A (ja) 2001-02-06
IL128893A0 (en) 2000-01-31
BR9711752A (pt) 2000-01-18
AU4310297A (en) 1998-04-02
US20030091581A1 (en) 2003-05-15
CA2264939C (en) 2012-06-05
CN1146445C (zh) 2004-04-21
EP0939651A1 (de) 1999-09-08
GB9618931D0 (en) 1996-10-23
DE69702209T2 (de) 2000-11-09
DK0939651T3 (da) 2000-09-04
ATE193452T1 (de) 2000-06-15
ES2148967T3 (es) 2000-10-16
US6495330B1 (en) 2002-12-17
CN1235556A (zh) 1999-11-17
AU715884B2 (en) 2000-02-10
CA2264939A1 (en) 1998-03-19
JP4457191B2 (ja) 2010-04-28
EP0939651B1 (de) 2000-05-31

Similar Documents

Publication Publication Date Title
DE69702209D1 (de) Stoffe und verfahren in zusammenhang mit der diagnose und therapie der präeclampsie
BG102265A (en) Soluble receptors for lymphotoxin-beta and antibodies against the receptor for lymphotoxin and its ligand as therapuetical substances for the threatment of immunological diseases
DE69738353D1 (de) Radiometall-bindende peptide analoge
CA2204616A1 (en) Ppar gamma antagonists for treating obesity
EP0738125A4 (de) Verfahren und vorrichtung zur behandlung krankhafter veränderungen des kreislaufsystems
MX9803253A (es) Metodo para el tratamiento de colitis establecida utilizando anticuerpos contra il-12.
ATE338818T1 (de) Verfahren zur diagnose des glaukoms
DE69510336T2 (de) Verfahren zur diagnose von praeklampsie
DE69735436D1 (de) Methode zum nachweis von zell-apoptose
MX9604183A (es) Metodo de examen para identificar ligandos para proteinas objetivo.
DE69523586D1 (de) Verfahren zum screening für die erkrankung crohn durch die verwendung von tnf-mikrosatelliten allelen
EP0368265A3 (de) Anlagen-Diagnoseapparat
DE69725606D1 (de) Methoden für die diagnose von allergischen atemwegsaspergillosen
HK1029622A1 (en) A method of diagnosis
WO1995027202A1 (en) Screening method using the rzr receptor family
DE59008975D1 (de) Verfahren zum überwachen von anlagen, wie autokrane, grossbagger oder dergleichen, und system zur verwirklichung dieses verfahrens.
DE3779612D1 (de) Verfahren zum testen eines modifizierten booth-multiplizierers, modifizierter booth-multiplizierer, geeignet zum testen mittels dieses verfahrens, und denselben enthaltende integrierte schaltung.
DE3765613D1 (de) Verfahren und vorrichtung zum herstellen von mit hinterschaeumten bezuegen versehenen polstern, insbesondere automobilsitzpolstern.
ATE477504T1 (de) Auf nmr basiertes verfahren zum erkennen von liganden, wobei ligand oder ziel hyperpolarisiert sind und das nmr-spektrum mit einem referenzspektrum des liganden oder ziels verglichen wird
DE69508605D1 (de) Proinsulin-peptid-verbindungen für den nachweis und die behandlung von typ-i-diabetes
DE69931644D1 (de) Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen
DE69610411D1 (de) Verfahren zur trennung von p-xylol, das eine vorbehandlung durch selektive hydrierung und eine behandlung mit aktiver erde umfasst
ATE228250T1 (de) Diagnosehilfe sowie verfahren zum nachweis der trächtigkeit von wiederkäuern
DE58904746D1 (de) Antikoerper, verfahren zu ihrer herstellung, klone zur erzeugung der antikoerper sowie verwendung der antikoerper zur diagnose und therapie von tumoren.
FRIEDMAN Inverse Problems in Wave Propagation(Final Report, 1 Nov. 1994- 30 Sep. 1995)

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: RODARIS PHARMACEUTICALS LTD., OXFORD, GB

8327 Change in the person/name/address of the patent owner

Owner name: SR PHARMA PLC, LONDON, GB